The sensitivity of acute myeloid leukemia cells to cytarabine is increased by suppressing the expression of Heme oxygenase-1 and hypoxia-inducible factor 1-alpha

Abstract Background Acute myeloid leukemia (AML), a malignancy Often resistant to common chemotherapy regimens (Cytarabine (Ara-c) + Daunorubicin (DNR)), is accompanied by frequent relapses. Many factors are involved in causing chemoresistance. Heme Oxygenase-1 (HO-1) and Hypoxia-Inducible Factor 1-...

Description complète

Détails bibliographiques

Auteurs principaux:	Mohammad Sadeghi, Asma Moslehi, Hadiseh Kheiry, Fariba Karoon Kiani, Asieh Zarei, Atefeh Khodakarami, Vahid Karpisheh, Ali Masjedi, Badrossadat Rahnama, Mohammad Hojjat-Farsangi, Mortaza Raeisi, Mehdi Yousefi, Ali Akbar Movasaghpour Akbari, Farhad Jadidi-Niaragh
Format:	Artigo
Langue:	Inglês
Publié:	BMC 2024-06-01
Collection:	Cancer Cell International
Sujets:	Cancer immunotherapy AML HO-1 HIF-1α Cytarabine Leukemia
Accès en ligne:	https://doi.org/10.1186/s12935-024-03393-3
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!